Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(COMPLETED)(P05786)
This study has been completed.
Study NCT00145509 Information provided by Merck Sharp & Dohme Corp.
First Received on September 1, 2005. Last Updated on October 25, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Affective Disorders, Psychotic
Interventions listed in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers